#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Peripheral T-cell lymphoma unspecified Biliary neoplasm Brain injury Trigeminal neuralgia Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Gaucher's disease type I Drug eruption Henoch-Schonlein purpura nephritis Retinal artery occlusion Bladder cancer Rhabdomyosarcoma Cutaneous T-cell lymphoma Eosinophilic oesophagitis Small cell lung cancer Infertility male More trials…

    Learn about Rare Diseases

    Combined immunodeficiency – Diagnostics Gaucher’s disease type I – Trials in Disease Anaplastic thyroid cancer – Basic Information Lymphangiosarcoma – Diagnostics Alexander disease Factor IX deficiency – Diagnostics Mucous membrane pemphigoid – Treatment Netherton’s syndrome – Trials in Disease Atypical teratoid/rhabdoid tumour of CNS – Life with Disease Systemic mastocytosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Giroctocogene Fitelparvovec Pyridoxine Argon PAPAVERINE HYDROCHLORIDE Medi0618 Ferric Derisomaltose Apixaban Warfarin Sodium Cefuroxime Sodium Imlifidase Rilvegostomig Vortioxetine Ht-29-A Cldn6 Car-T(A) Iti-1284 Axicabtagene Ciloleucel Mesalazine Rituximab Lithium Carbonate Ketamine Hydrochloride More therapies…

    Learn about Your Condition

    Osteoporosis postmenopausal Vertebrobasilar stroke Respiratory tract infection Hepato-lenticular degeneration Peripheral artery stenosis Leukaemia Meniscus injury Small cell carcinoma Cardiac arrest Endometrial cancer stage II Autoimmune haemolytic anaemia Lymphocytic lymphoma Procedural hypotension Supraventricular tachycardia Palpitations More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Romania

  • Study on the Safety of Avelumab for Patients with Solid Tumors Continuing Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Avelumab
    Bulgaria France Hungary Italy Poland Romania +1
  • Study on Tulisokibart for Treating Moderate to Severe Crohn’s Disease in Adults

    Not recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Tulisokibart
    Austria Belgium Croatia Czechia Denmark Finland +15
  • Study on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Colestyramine
    • Teriflunomide
    • Frexalimab
    Austria Bulgaria Croatia Czechia Denmark France +10
  • Study on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus

    Not recruiting

    3 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Cenerimod
    Bulgaria France Greece Poland Romania
  • Study of Cabozantinib in Adults with Progressive Thyroid Cancer Who Did Not Respond to Previous Treatment with Radioactive Iodine and VEGFR Therapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Thyroid cancer
    Investigated Drugs:
    • Cabozantinib
    Poland Romania Spain
  • Study on the Safety and Effectiveness of Volrustomig with a Drug Combination for Patients with Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Ramucirumab
    • Volrustomig
    • Infliximab
    France Greece Italy Portugal Romania Spain
Previous Page
1 … 125 126 127 128 129 … 131
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Carboplatin Cisplatin Nivolumab Paclitaxel Pemetrexed Sodium Chloride Docetaxel Fluorouracil Dexamethasone Durvalumab Rituximab Capecitabine Oxaliplatin Prednisolone Paclitaxel Albumin-Bound Etoposide Paracetamol Gemcitabine Mycophenolate Mofetil Atezolizumab Pemetrexed Disodium Trospium Chloride Xanomeline Tartrate Dapagliflozin Bevacizumab Semaglutide Tocilizumab Lenalidomide Ipilimumab Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acquired antithrombin III deficiency Acromegaly Acute cardiac event Acute coronary syndrome Acute haemorrhagic ulcerative colitis Acute lymphocytic leukaemia Acute lymphocytic leukaemia recurrent Acute myeloid leukaemia Acute myocardial infarction Acute promyelocytic leukaemia Acute respiratory distress syndrome Acute respiratory failure Adenocarcinoma Adenocarcinoma gastric Adenocarcinoma pancreas Adrenogenital syndrome Alcohol use disorder Alopecia areata Alveolar proteinosis Anaemia Anaemia of chronic disease Anaplastic lymphoma kinase gene mutation Angina pectoris Anhedonia Anti-neutrophil cytoplasmic antibody positive vasculitis Antithrombin III deficiency Arteriosclerosis Arteriovenous graft thrombosis Asthma Atrial fibrillation Autism spectrum disorder Autonomic nervous system imbalance Axial spondyloarthritis B-cell lymphoma B-cell small lymphocytic lymphoma Bacterial vaginosis Bipolar disorder Bipolar I disorder Bladder cancer Bladder cancer stage 0 with cancer in situ Bladder cancer stage I with cancer in situ Bladder transitional cell carcinoma stage IV Breast cancer Breast cancer female Breast cancer metastatic Bronchiectasis Cachexia Carcinoid syndrome Cardiac failure Cardiac failure chronic Cardiomyopathy Cardiovascular disorder Cerebrovascular accident prophylaxis Cervix carcinoma Cervix carcinoma recurrent Cholangiocarcinoma Cholangitis sclerosing Chronic cutaneous lupus erythematosus Chronic hepatitis Chronic hepatitis B Chronic hepatitis C Chronic inflammatory demyelinating polyradiculoneuropathy Chronic kidney disease Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia recurrent Chronic myeloid leukaemia Chronic myelomonocytic leukaemia Chronic obstructive pulmonary disease Chronic rhinosinusitis with nasal polyps Chronic rhinosinusitis without nasal polyps Clear cell papillary renal cell carcinoma Clear cell renal cell carcinoma Clostridium difficile infection Coagulation factor X level Coeliac disease Cold urticaria Colitis ulcerative Colorectal adenocarcinoma Colorectal cancer Colorectal cancer metastatic Colorectal cancer stage IV Congenital growth hormone deficiency Conjunctivitis allergic Connective tissue disorder Contraception COVID-19 Craniocerebral injury Crohn's disease Cushing's syndrome Cutaneous lupus erythematosus Dementia Alzheimer's type Dementia of the Alzheimer's type with delusions Dermatitis Dermatitis atopic Dermatomyositis Diabetes mellitus Diabetic foot infection Diffuse large B-cell lymphoma Dilated cardiomyopathy Dry age-related macular degeneration Dry eye Duchenne muscular dystrophy Dyslipidaemia EGFR gene mutation Embolism Endocrine ophthalmopathy Endometrial adenocarcinoma Endometrial cancer Endometriosis Epilepsy Epstein-Barr virus associated lymphoma Erosive oesophagitis Essential thrombocythaemia Eyelid ptosis Fabry's disease Factor IX deficiency Factor VIII deficiency Fallopian tube cancer Familial hypertriglyceridaemia Focal segmental glomerulosclerosis Follicle centre lymphoma follicular grade I, II - III Follicular lymphoma Gastric cancer Gastric cancer recurrent Gastroenteropancreatic neuroendocrine tumour disease Gastrointestinal cancer metastatic Gastrooesophageal cancer Gastrooesophageal reflux disease Gingival bleeding Glioma Growth hormone deficiency Haemolytic uraemic syndrome Haemophilia Haemophilia A without inhibitors Haemophilia B without inhibitors Haemorrhage prophylaxis Head and neck cancer Head and neck cancer metastatic Heparin resistance Hepatic cirrhosis Hepatitis B Hepatitis D Hepatobiliary cancer Hepatocellular carcinoma HER2 mutant non-small cell lung cancer HER2 positive breast cancer HER2 positive gastric cancer Hereditary angioedema Hereditary angioedema with C1 esterase inhibitor deficiency Hereditary haemochromatosis Hidradenitis High-grade B-cell lymphoma HIV infection Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-dependent prostate cancer Hormone-refractory prostate cancer Hot flush Human epidermal growth factor receptor negative Human papilloma virus test Huntington's disease Hyperadrenocorticism Hyperchylomicronaemia Hypereosinophilic syndrome Hyperkalaemia Hypertension Hypertriglyceridaemia Hypertrophic cardiomyopathy Hypoparathyroidism Hypophosphatasia Idiopathic pulmonary fibrosis Immune thrombocytopenia Influenza Interstitial lung disease Iron deficiency Ischaemic stroke Juvenile absence epilepsy Juvenile idiopathic arthritis K-ras gene mutation Lennox-Gastaut syndrome Lipoprotein metabolism disorder Lung adenocarcinoma Lung neoplasm malignant Lupus nephritis Major depression Malignant lymphoid neoplasm Malignant melanoma Malignant melanoma stage II Malignant melanoma stage III Malignant melanoma stage IV Malignant peritoneal neoplasm Mania Mantle cell lymphoma Marginal zone lymphoma Medullary thyroid cancer Meningococcal infection Metabolic dysfunction-associated liver disease Metabolic dysfunction-associated steatohepatitis Metastatic gastric cancer Metastatic malignant melanoma Metastatic renal cell carcinoma Microsatellite instability cancer Migraine Migraine with aura Migraine without aura Multiple sclerosis Myasthenia gravis Myelodysplastic syndrome Myelofibrosis Myocardial infarction Myocardial ischaemia Neoplasm Neoplasm malignant Nephrogenic anaemia Neurodermatitis Neurogenic bladder Non-alcoholic steatohepatitis Non-Hodgkin's lymphoma Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer recurrent Non-small cell lung cancer stage I Non-small cell lung cancer stage II Non-small cell lung cancer stage III Non-small cell lung cancer stage IIIA Non-small cell lung cancer stage IIIB Non-small cell lung cancer stage IV Obesity Oesophageal adenocarcinoma Oesophageal adenocarcinoma stage II Oesophageal adenocarcinoma stage III Oesophageal cancer metastatic Oesophageal carcinoma Oesophageal squamous cell carcinoma Oesophageal squamous cell carcinoma stage II Oesophageal squamous cell carcinoma stage III Osteoarthritis Osteochondrodysplasia Ovarian cancer Ovarian cancer metastatic Ovarian cancer recurrent Ovarian cancer stage III Ovarian cancer stage IV Ovarian epithelial cancer Ovarian epithelial cancer recurrent Overweight Pancreatic carcinoma metastatic Papilloma viral infection Paroxysmal nocturnal haemoglobinuria Partial seizures Pemphigoid Petit mal epilepsy Philadelphia positive acute lymphocytic leukaemia Pituitary-dependent Cushing's syndrome Plasma cell myeloma Plasma cell myeloma refractory Platelet aggregation Platelet aggregation inhibition Platelet aggregation test Pneumonia Portal hypertension Postoperative wound infection Prader-Willi syndrome Primary biliary cholangitis Primary myelofibrosis Primary progressive multiple sclerosis Progressive multiple sclerosis Progressive relapsing multiple sclerosis Prophylaxis of nausea and vomiting Prostate cancer Prostate cancer metastatic Psoriasis Psoriatic arthropathy Psychotic disorder Pulmonary arterial hypertension Pulmonary hypertension Pulmonary tuberculosis Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Renal cancer metastatic Renal cancer stage IV Renal cell carcinoma Renal disorder Respiratory syncytial virus infection Retinopathy of prematurity Rheumatoid arthritis Schizophrenia Secondary immunodeficiency Secondary progressive multiple sclerosis Short stature Sjogren's syndrome Skin bacterial infection Skin cancer Skin neoplasm excision Skin squamous cell carcinoma metastatic Skin squamous cell carcinoma recurrent Small cell lung cancer Small cell lung cancer extensive stage Small cell lung cancer limited stage Small cell lung cancer metastatic Small cell lung cancer recurrent Squamous cell carcinoma Squamous cell carcinoma of head and neck Squamous cell carcinoma of lung Squamous cell carcinoma of skin Still's disease Stress Subacute cutaneous lupus erythematosus Systemic candida Systemic lupus erythematosus Systemic scleroderma Thrombocytopenia Thrombocytosis Thrombosis prophylaxis Thyroid cancer Tourette's disorder Transitional cell cancer of the renal pelvis and ureter Transitional cell carcinoma Transitional cell carcinoma metastatic Triple negative breast cancer Type 1 diabetes mellitus Type 2 diabetes mellitus Urinary incontinence Urinary tract infection Urticaria cholinergic Urticaria chronic Varicella Vomiting Vulvovaginal candidiasis Warm autoimmune haemolytic anaemia Weight control

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!